Lexicon Pharmaceuticals, Inc. (LXRX) ownership: Top institutional holder: Artal Group S.A. ($241.39M). Insider activity: Net Seller (1 buys, 19 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| Artal Group S.A. | 154734327.00 | $241.39M | 2026-03-31 |
| FMR LLC | 45056338.00 | $70.29M | 2026-03-31 |
| Siren, L.L.C. | 44303518.00 | $69.11M | 2026-03-31 |
| BlackRock Fund Advisors | 2977143.00 | $41.17M | 2016-12-31 |
| Sessa Capital IM, L.P. | 17912961.00 | $27.94M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 9519167.00 | $14.85M | 2026-03-31 |
| Point72 Asset Management, L.P. | 7814606.00 | $12.19M | 2026-03-31 |
| VANGUARD GROUP INC | 9606549.00 | $11.05M | 2025-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 | |
| Sell | null | 2026-05-01 |
Back to LXRX overview · LXRX earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.